Under construction – not a live service
Sign in
Taking people in United StatesEarly phase 1

Studies how nerves raise blood pressure in obesity-linked high blood pressure

Studies nerve signals and blood vessel response in adults with obesity and high blood pressure.

Plain-language title generated from the registry record
Registry title: Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Key facts

Where
Dallas, United StatesSee the site
Phase
Early phase 1

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 55 years old?

Source: NCT04838678, who can take part

Where in United States

  • University of Texas Southwestern Medical CenterDallas, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Texas Southwestern Medical Center
Trial code
NCT04838678
Record updated
3 September 2026
Original description
The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function. The study will involve measuring sympathetic nervous system activity and blood flow during common laboratory physiological stress protocols (e.g. hypoxia, exercise), and in response to infusion of drugs that cause vasodilation or vasoconstriction.Read full original descriptionShow less

Sympathetic Neural Patterns and Transduction in Obesity-associated Hypertension

The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function. The study will involve measuring sympathetic nervous system activity and blood flow during common laboratory physiological stress protocols (e.g. hypoxia, exercise), and in response to infusion of drugs that cause vasodilation or vasoconstriction.

Inclusion: Control - BMI<30, age 18-55; Hypertensive - BMI<30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring Obese- BMI>30, age 18-55 Obese-hypertensive- BMI>30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring.

Exclusion: All groups - presence of other significant cardiovascular disease, renal disease, history of smoking, diabetes,.

ClinicalTrials.gov NCT04838678